Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hanley N. Abramson
Kinase Inhibitors as Potential Agents in the Treatment of Multiple Myeloma
Oncotarget
Oncology
Related publications
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
Pharmaceuticals
Molecular Medicine
Pharmaceutical Science
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Investigational Agents in Immunotherapy: A New Horizon for the Treatment of Multiple Myeloma
British Journal of Haematology
Hematology
Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy
Journal of Cell Science & Therapy
CHIR-258, a Novel, Multitargeted Tyrosine Kinase Inhibitor for the Potential Treatment of T(4;14) Multiple Myeloma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents
New Insights Into the Treatment of Multiple Myeloma With Histone Deacetylase Inhibitors
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Histone Deacetylase Inhibitors in Multiple Myeloma
Hematology Reports
Hematology
Treatment of Multiple Myeloma in Akita: Features and Outcomes in the Era of Novel Agents
Journal of clinical and experimental hematopathology : JCEH
Medicine
